Cholecystokinin peptides in vitro modulate the characteristics of the striatal 3H-N-propylnorapomorphine sites.
D000818:Animals; D001058:Apomorphine / Q000031:analogs & derivatives* / Q000378:metabolism; D002462:Cell Membrane / Q000378:metabolism; D003342:Corpus Striatum / Q000378:metabolism*; D005755:Gastrins / Q000494:pharmacology*; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D011954:Receptors, Dopamine / Q000378:metabolism*; D012844:Sincalide / Q000494:pharmacology*; D013134:Spiperone / Q000378:metabolism; D013758:Tetragastrin / Q000494:pharmacology*
D005755:Gastrins; D011954:Receptors, Dopamine; D013758:Tetragastrin; D013134:Spiperone; C009074:N-n-propylnorapomorphine; D012844:Sincalide; D001058:Apomorphine